Gotham Asset Management LLC Acquires 1,917 Shares of McKesson Corporation $MCK

Gotham Asset Management LLC increased its holdings in shares of McKesson Corporation (NYSE:MCK) by 5.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 38,428 shares of the company’s stock after buying an additional 1,917 shares during the period. Gotham Asset Management LLC’s holdings in McKesson were worth $29,687,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Obsidian Personal Planning Solutions LLC raised its stake in shares of McKesson by 2.9% during the third quarter. Obsidian Personal Planning Solutions LLC now owns 426 shares of the company’s stock valued at $346,000 after acquiring an additional 12 shares during the last quarter. IAM Advisory LLC lifted its holdings in shares of McKesson by 0.3% during the third quarter. IAM Advisory LLC now owns 3,908 shares of the company’s stock worth $3,019,000 after purchasing an additional 13 shares during the period. PDS Planning Inc grew its stake in shares of McKesson by 1.1% in the third quarter. PDS Planning Inc now owns 1,209 shares of the company’s stock worth $934,000 after purchasing an additional 13 shares during the last quarter. Berkshire Asset Management LLC PA grew its stake in shares of McKesson by 4.6% in the third quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company’s stock worth $227,000 after purchasing an additional 13 shares during the last quarter. Finally, Goldstein Advisors LLC increased its holdings in McKesson by 4.4% in the third quarter. Goldstein Advisors LLC now owns 334 shares of the company’s stock valued at $258,000 after purchasing an additional 14 shares during the period. 85.07% of the stock is owned by institutional investors.

McKesson Stock Up 0.3%

MCK stock opened at $943.43 on Tuesday. The firm has a market cap of $115.56 billion, a price-to-earnings ratio of 27.13, a PEG ratio of 1.51 and a beta of 0.38. The company’s fifty day simple moving average is $896.29 and its 200 day simple moving average is $828.19. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same period last year, the business posted $8.03 EPS. The business’s revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Research analysts expect that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.3%. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Raymond James Financial set a $970.00 target price on McKesson in a research report on Thursday, March 5th. Barclays upped their price target on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research report on Wednesday, February 18th. Evercore reissued an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Mizuho raised their price objective on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Finally, Wall Street Zen lowered McKesson from a “buy” rating to a “hold” rating in a research note on Saturday. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $960.93.

Insiders Place Their Bets

In other McKesson news, EVP Leann B. Smith sold 190 shares of the stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the transaction, the executive vice president directly owned 2,989 shares in the company, valued at approximately $2,824,605. This represents a 5.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 in the last 90 days. Company insiders own 0.08% of the company’s stock.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.